恒瑞医药第三季度营收、利润稳健增长，营收达65.89亿元人民币，同比增长12.72%。前三季度，恒瑞医药利润、每股收益双双涨超30%，主要原因是公司将收到的Merck Healthcare 1.6亿欧元对外许可首付款确认为收入，利润增加较多。

“China for us is now the second-largest market in the world, and not only from a customer perspective, but also from a source ...

The parallel session of the 7th Hongqiao International Economic Forum (HQF)—Pudong and the World: High-Standard Institutional ...